RECENT ADVANCES IN
MANAGEMENT OF
URETERIC CALCULI
-DR.NAVYA TEJA
URETERIC CALCULI
• ALWAYS OF RENAL ORIGIN.
• CAN IMPACTED AT VARIOUS
NARROW JUNCTIONS.
• NATURE OF THE STONES
SIMILAR TO RENAL STONES.
TYPES OF CALCULI
CALCIUM OXALATE
STONES (75%)
PHOSPHATE
STONES
URIC ACID STONES
STRUVITE STONES CYSTINE STONES XANTINE STONES
CLINICAL
FEATURES
• MOST OF THEM PRESENT BETWEEN THE AGES 30 & 50
• MALE PREPONDERANCE
• PAIN- COLICKY TYPE,
RADIATES FROM LOIN TO GROIN OFTEN TO THE TIP
OF GENITALIA
• NAUSEA ,VOMITTING, SWEATING DUE TO REFLUX
PYLOROSPASM
• HEMATURIA,DYSURIA,FREQUENCY,STRANGURY
• TENDERNESS IN ILIAC FOSSA ( NO REBOUND
TENDERNESS)
INVESTIGATIONS
• NON-CONTRAST CT SCAN- DIAGNOSTIC
• X-RAY KUB
• URINE ROUTINE & MICROSCOPY,C/S
• SERUM UREA & CREATININE
• SERUM CALCIUM & URIC ACID
• IVU
DIFFERENTIAL
DIAGNOSIS
APPENDICITIS
CHOLECYSTITIS
OVARIAN CYST
MESENTERIC ADENITIS
RUPTURED ECTOPIC GESTATION
TUBO-OVARIAN DISEASE
INDICATIONS FOR CONSERVATIVE MANAGEMENT
• Single stone less than or equal to 5 mm
• Stone in lower one third of ureter
• Ureter is undilated
• Evidence of downward movement
APPROACHES
FOR REMOVAL
OF URETERIC
CALCULI
EXTRACORPOREAL SHOCK WAVE
LITHOTRIPSY(ESWL)
• NON-INVASIVE
• SHOCKWAVES GENERATED OUTSIDE THE BODY & FOCUSSED
ON THE STONES
• DIFFERENT METHODS INCLUDE SPARK
GAP,ELECTROMAGNETIC,PIEZOELECTRIC & MICROEXPULSIVE
• SHOCK WAVES GENERATED BY SPARK-GAP METHOD NEED TO
BE COORDINATED WITH ECG TO PREVENT CARDIAC
ARRHYTHMIAS.
• STONES UPTO 1.5 CM
• STEINSTRASSE
INDICATIONS FOR ESWL
• INDIVIDUALS WHO WORK IN PROFESSIONS IN WHICH UNEXPECTED SYMPTOMS
OF STONE PASSAGE MAY PROMT DANGEROUS SITUATIONS.
• INDIVIDUALS WITH SOLITARY KIDNEYS.
• PATIENTS WITH HYPERTENSION ,DIABETES & OTHER MEDICAL CONDITIONS
THAT PREDISPOSE TO RENAL INSUFFICIENCY
ABSOLUTE
CONTRAINDICATIONS
FOR ESWL
ACUTE UTI
UNCORRECTED BLEEDING DISORDERS
PREGNANCY
UNCORRECTED OBSTRUCTION DISTAL TO THE
STONE
RELATIVE
CONTRAINDICATIONS
FOR ESWL
• MORBID OBESE PATIENTS
• PATIENTS WITH ORTHOPEDIC OR SPINAL
DEFORMITIES
• RENAL ECTOPIA
• POORLY CONTROLLED HYPERTENSION
• RENAL INSUFFICIENCY
PREEXISTING CARDIAC & PULMONARY ARE NOT CONTRAINDICATIONS
COMPLICATIONS OF ESWL
• BACTERIURIA
• HEMATURIA
• PARENCHYMAL HEMORRHAGE
• PERIRENAL HAEMATOMA
MORE THAN ONE TREATMENT SESSION MAY BE NEEDED TO TREAT THE STONE
URETEROSCOPY
• Upper urinary tract endoscopy performed most
commonly with endoscope passed through the
urethra,bladder & then directly into upper urinary
tract.
DIAGNOSTIC
INDICATONS OF
URETEROSCOPY
ABNORMAL IMAGE FINDNGS- FILLING DEFECT
OBSTRUCTON – DETERMINATION OF ETIOLOGY
LOCALISING THE SOURCE OF POSITIVE URINARY CYTOLOGY
RESULTS
EVALUATION OF URETERAL INJURY
SURVEILLANCE WITH KNOWN HISTORY OF UROTHELIAL
MALIGNANCY
THERAPEUTIC
INDICATIONS
FOR
URETEROSCOPY
ENDOSCOPIC LITHOTRIPSY
RETROGRADE ENDOPYELOTOM Y
INCISION OF URETERAL STRICTURES
IMPROVEMENT OF CALYCEAL DRAINAGE
TREATMENT OF MALIGNANT URTHELIAL TUMOURS
TREATMENT OF BENIGN TUMOURS & BLEEDING LESIONS
INDICATIONS FOR DORMIA BASKETING
• STONE IN LOWER ONE THIRD
• STONE LESS THAN 10MM SIZE
• STONE BELOW PELVIC BRIM
• SINGLE STONE
CONTRAINDICATIONS FOR URETEROSCOPY
UNTREATED UTI
ENDOSCOPY WITHOUT
APPROPRIATE
ANTIBIOTIC COVERAGE
UNCORRECTED
BLEEDING DISORDERS
COMPLICATIONS OF URETEROSCOPY
• INJURY TO URETERIC MUCOSA/WALL
• URETERIC PERFORATION & EXTRAVASATION
• AVULSION OF URETER
PERCUTANEOUS NEPHROLITHOTOMY
• TECHNIQUE USED TO TREAT LARGE STONES IN RENAL PELVIS &
CALYCES,SOMETIMES IN PROXIMAL URETER
• A TRACT IS ESTABLISHED INTO RENAL COLLECTING SYSTEM USING
USG/FLUOROSCOPIC GUIDANCE
• A SERIES OF DILATORS IS USED FOLLOWED BY PLACEMENT OF WORKING
SHEATH INTO THE COLLECTING SYSTEM THROUGH WHICH STONE IS
VISUALISED & FRAGMENTED ( USING USG/LASER/LITHOCAST)
• NEPHROSTOMY TUBE IS LEFT IN THE KIDNEY FOR 24-48 HRS
PCNL-INDICATIONS
• OBSTRUCTION- Anatomical obstruction such as PUJ obstruction,calyceal
diverticula,ureteric stricture preventing the passage of stone fragments after
ESWL
• Obese patients in whom ESWL is contraindicated
• LOWER CALYCEAL STONES
• Struvite stones- need to be removed completely because of associated infection
• Calcium oxalate monohydrate & cystine stones- difficult to fragment using ESWL
• ANTEGRADE URETERAL STENTING
PCNL- COMPLICATIONS
• INJURY TO SPLEEN,PLEURA & COLON
• HEMORRAGE FROM RENAL PARENCHYMA,SOMETIMES EVEN FROM RENAL
VESSELS ( EMBOLISATIONNEPHRECTOMY)
• SEPSIS
• EXTRAVASATION DUE TO RUPTURE OF COLLECTING SYSTEM
• RETAINED STONE FRAGMENTS
• OPEN SURGERY
MEDICAL
MANAGEMENT
OF STONES
GOAL IS TO PREVENT FORMATION OF NEW
STONES/FURTHER GROWTH OF EXISTING STONES
HIGH FLUID INTAKE TO PREVENT
SUPERSATURATION OF URINE
AIM OF PRODUCING ATLEAST 2.5L OF URINE IN 24
HRS
THIAZIDE DIURETICS-REDUCE URINARY CALCIUM EXCRETION BY
INCREASING FRACTIONAL CALCIUM REABSORPTION IN DISTAL
NEPHRON.
ORTHOPHOSPHATES –USED TO DECREASE CALCIUM EXCRETION &
INCREASE INHIBITOR ACTIVITY
MANAGEMENT
BASED ON TYPE
OF STONE
• FOR URIC ACID STONES- LOW PURINE
DIET,ALKALISATION OF URINE & HYDRATION.
ALLOPURINOL
• FOR STRUVITE STONES-LOW CALCIUM &
PHOSPHORUS DIET
• FOR CYSTEINE STONES-LOW METHIONE
DIET,ALKALISATION OF URINE,CYSTEINE
COMPLEXING AGENTS- D-PENCILLAMINE &
ALPHA MERCAPTOPROPIONYL GLYCINE
MEDICAL
EXPULSIVE
THERAPY
ALPHA ADRENOCEPTOR ANTAGONISTS
CALCIUM CHANNEL BLOCKERS
CORTICOSTEROIDS
ALPHA
ADRENOCEPTOR
ANTAGONISTS
• TAMSULOSIN (MC),ALFUZOCIN,TERAZOCIN
• CAPABLE OF DECREASING THE RESTING TONE OF
THE URETER,INTERFERING WITH URETERIC
CONTRACTIONS,THEREBY DECREASING THE
FREQUENCY OF PERISTALTIC CONTRACTIONS
• SEVERAL STUDIES D DEMONSTRATED THAT
ALPHA BLOCKERS EXPEDITE STONE
PASSAGE,DECREASE PAIN & HENCE DECREASE
ANALGESIC REQUIREMENTS
CALCIUM CHANNEL BLOCKERS
NIFIDIPINE – MC
BETTER RESULTS WHEN GIVEN ALONG WITH CORTICOSTEROIDS
STUDIES COMPARING NIFIDIPINE AGAINST TAMSULOSIN SHOW TAMSULOSIN MORE EFFICACIOUS
CORTICOSTEROIDS
• REDUCES STONE INDUCED EDEMA & HENCE
ALLOW CALCULUS TO PASS
• STEROIDS COMBINED WITH AN ALPHA BLOCKER
PROVED MORE EFFICACIOUS THAN EITHER
STEROID OR ALPHA BLOCKER ALONE .
• STUDIES COMPARED
TAMSULOSIN,DEFLAZOCORT,COMBINATION OF
BOTH,ANALGESICS SHOWS RATE OF EXPULSION
60%,37.5%,84.8%,33.3%
URETERIC CALCULI
URETERIC CALCULI

URETERIC CALCULI

  • 1.
    RECENT ADVANCES IN MANAGEMENTOF URETERIC CALCULI -DR.NAVYA TEJA
  • 2.
    URETERIC CALCULI • ALWAYSOF RENAL ORIGIN. • CAN IMPACTED AT VARIOUS NARROW JUNCTIONS. • NATURE OF THE STONES SIMILAR TO RENAL STONES.
  • 3.
    TYPES OF CALCULI CALCIUMOXALATE STONES (75%) PHOSPHATE STONES URIC ACID STONES STRUVITE STONES CYSTINE STONES XANTINE STONES
  • 4.
    CLINICAL FEATURES • MOST OFTHEM PRESENT BETWEEN THE AGES 30 & 50 • MALE PREPONDERANCE • PAIN- COLICKY TYPE, RADIATES FROM LOIN TO GROIN OFTEN TO THE TIP OF GENITALIA • NAUSEA ,VOMITTING, SWEATING DUE TO REFLUX PYLOROSPASM • HEMATURIA,DYSURIA,FREQUENCY,STRANGURY • TENDERNESS IN ILIAC FOSSA ( NO REBOUND TENDERNESS)
  • 5.
    INVESTIGATIONS • NON-CONTRAST CTSCAN- DIAGNOSTIC • X-RAY KUB • URINE ROUTINE & MICROSCOPY,C/S • SERUM UREA & CREATININE • SERUM CALCIUM & URIC ACID • IVU
  • 6.
  • 7.
    INDICATIONS FOR CONSERVATIVEMANAGEMENT • Single stone less than or equal to 5 mm • Stone in lower one third of ureter • Ureter is undilated • Evidence of downward movement
  • 8.
  • 9.
    EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY(ESWL) •NON-INVASIVE • SHOCKWAVES GENERATED OUTSIDE THE BODY & FOCUSSED ON THE STONES • DIFFERENT METHODS INCLUDE SPARK GAP,ELECTROMAGNETIC,PIEZOELECTRIC & MICROEXPULSIVE • SHOCK WAVES GENERATED BY SPARK-GAP METHOD NEED TO BE COORDINATED WITH ECG TO PREVENT CARDIAC ARRHYTHMIAS. • STONES UPTO 1.5 CM • STEINSTRASSE
  • 11.
    INDICATIONS FOR ESWL •INDIVIDUALS WHO WORK IN PROFESSIONS IN WHICH UNEXPECTED SYMPTOMS OF STONE PASSAGE MAY PROMT DANGEROUS SITUATIONS. • INDIVIDUALS WITH SOLITARY KIDNEYS. • PATIENTS WITH HYPERTENSION ,DIABETES & OTHER MEDICAL CONDITIONS THAT PREDISPOSE TO RENAL INSUFFICIENCY
  • 12.
    ABSOLUTE CONTRAINDICATIONS FOR ESWL ACUTE UTI UNCORRECTEDBLEEDING DISORDERS PREGNANCY UNCORRECTED OBSTRUCTION DISTAL TO THE STONE
  • 13.
    RELATIVE CONTRAINDICATIONS FOR ESWL • MORBIDOBESE PATIENTS • PATIENTS WITH ORTHOPEDIC OR SPINAL DEFORMITIES • RENAL ECTOPIA • POORLY CONTROLLED HYPERTENSION • RENAL INSUFFICIENCY PREEXISTING CARDIAC & PULMONARY ARE NOT CONTRAINDICATIONS
  • 14.
    COMPLICATIONS OF ESWL •BACTERIURIA • HEMATURIA • PARENCHYMAL HEMORRHAGE • PERIRENAL HAEMATOMA MORE THAN ONE TREATMENT SESSION MAY BE NEEDED TO TREAT THE STONE
  • 15.
    URETEROSCOPY • Upper urinarytract endoscopy performed most commonly with endoscope passed through the urethra,bladder & then directly into upper urinary tract.
  • 17.
    DIAGNOSTIC INDICATONS OF URETEROSCOPY ABNORMAL IMAGEFINDNGS- FILLING DEFECT OBSTRUCTON – DETERMINATION OF ETIOLOGY LOCALISING THE SOURCE OF POSITIVE URINARY CYTOLOGY RESULTS EVALUATION OF URETERAL INJURY SURVEILLANCE WITH KNOWN HISTORY OF UROTHELIAL MALIGNANCY
  • 18.
    THERAPEUTIC INDICATIONS FOR URETEROSCOPY ENDOSCOPIC LITHOTRIPSY RETROGRADE ENDOPYELOTOMY INCISION OF URETERAL STRICTURES IMPROVEMENT OF CALYCEAL DRAINAGE TREATMENT OF MALIGNANT URTHELIAL TUMOURS TREATMENT OF BENIGN TUMOURS & BLEEDING LESIONS
  • 19.
    INDICATIONS FOR DORMIABASKETING • STONE IN LOWER ONE THIRD • STONE LESS THAN 10MM SIZE • STONE BELOW PELVIC BRIM • SINGLE STONE
  • 20.
    CONTRAINDICATIONS FOR URETEROSCOPY UNTREATEDUTI ENDOSCOPY WITHOUT APPROPRIATE ANTIBIOTIC COVERAGE UNCORRECTED BLEEDING DISORDERS
  • 21.
    COMPLICATIONS OF URETEROSCOPY •INJURY TO URETERIC MUCOSA/WALL • URETERIC PERFORATION & EXTRAVASATION • AVULSION OF URETER
  • 22.
    PERCUTANEOUS NEPHROLITHOTOMY • TECHNIQUEUSED TO TREAT LARGE STONES IN RENAL PELVIS & CALYCES,SOMETIMES IN PROXIMAL URETER • A TRACT IS ESTABLISHED INTO RENAL COLLECTING SYSTEM USING USG/FLUOROSCOPIC GUIDANCE • A SERIES OF DILATORS IS USED FOLLOWED BY PLACEMENT OF WORKING SHEATH INTO THE COLLECTING SYSTEM THROUGH WHICH STONE IS VISUALISED & FRAGMENTED ( USING USG/LASER/LITHOCAST) • NEPHROSTOMY TUBE IS LEFT IN THE KIDNEY FOR 24-48 HRS
  • 24.
    PCNL-INDICATIONS • OBSTRUCTION- Anatomicalobstruction such as PUJ obstruction,calyceal diverticula,ureteric stricture preventing the passage of stone fragments after ESWL • Obese patients in whom ESWL is contraindicated • LOWER CALYCEAL STONES • Struvite stones- need to be removed completely because of associated infection • Calcium oxalate monohydrate & cystine stones- difficult to fragment using ESWL • ANTEGRADE URETERAL STENTING
  • 25.
    PCNL- COMPLICATIONS • INJURYTO SPLEEN,PLEURA & COLON • HEMORRAGE FROM RENAL PARENCHYMA,SOMETIMES EVEN FROM RENAL VESSELS ( EMBOLISATIONNEPHRECTOMY) • SEPSIS • EXTRAVASATION DUE TO RUPTURE OF COLLECTING SYSTEM • RETAINED STONE FRAGMENTS • OPEN SURGERY
  • 26.
    MEDICAL MANAGEMENT OF STONES GOAL ISTO PREVENT FORMATION OF NEW STONES/FURTHER GROWTH OF EXISTING STONES HIGH FLUID INTAKE TO PREVENT SUPERSATURATION OF URINE AIM OF PRODUCING ATLEAST 2.5L OF URINE IN 24 HRS
  • 27.
    THIAZIDE DIURETICS-REDUCE URINARYCALCIUM EXCRETION BY INCREASING FRACTIONAL CALCIUM REABSORPTION IN DISTAL NEPHRON. ORTHOPHOSPHATES –USED TO DECREASE CALCIUM EXCRETION & INCREASE INHIBITOR ACTIVITY
  • 28.
    MANAGEMENT BASED ON TYPE OFSTONE • FOR URIC ACID STONES- LOW PURINE DIET,ALKALISATION OF URINE & HYDRATION. ALLOPURINOL • FOR STRUVITE STONES-LOW CALCIUM & PHOSPHORUS DIET • FOR CYSTEINE STONES-LOW METHIONE DIET,ALKALISATION OF URINE,CYSTEINE COMPLEXING AGENTS- D-PENCILLAMINE & ALPHA MERCAPTOPROPIONYL GLYCINE
  • 29.
  • 30.
    ALPHA ADRENOCEPTOR ANTAGONISTS • TAMSULOSIN (MC),ALFUZOCIN,TERAZOCIN •CAPABLE OF DECREASING THE RESTING TONE OF THE URETER,INTERFERING WITH URETERIC CONTRACTIONS,THEREBY DECREASING THE FREQUENCY OF PERISTALTIC CONTRACTIONS • SEVERAL STUDIES D DEMONSTRATED THAT ALPHA BLOCKERS EXPEDITE STONE PASSAGE,DECREASE PAIN & HENCE DECREASE ANALGESIC REQUIREMENTS
  • 31.
    CALCIUM CHANNEL BLOCKERS NIFIDIPINE– MC BETTER RESULTS WHEN GIVEN ALONG WITH CORTICOSTEROIDS STUDIES COMPARING NIFIDIPINE AGAINST TAMSULOSIN SHOW TAMSULOSIN MORE EFFICACIOUS
  • 32.
    CORTICOSTEROIDS • REDUCES STONEINDUCED EDEMA & HENCE ALLOW CALCULUS TO PASS • STEROIDS COMBINED WITH AN ALPHA BLOCKER PROVED MORE EFFICACIOUS THAN EITHER STEROID OR ALPHA BLOCKER ALONE . • STUDIES COMPARED TAMSULOSIN,DEFLAZOCORT,COMBINATION OF BOTH,ANALGESICS SHOWS RATE OF EXPULSION 60%,37.5%,84.8%,33.3%